SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-043971
Filing Date
2020-07-29
Accepted
2020-07-29 18:22:05
Documents
2
Period of Report
2020-07-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1661
2 POA DOCUMENT poa.txt EX-24.3_930448 3769
  Complete submission text file 0001209191-20-043971.txt   6907
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Issuer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SIERRA ONCOLOGY, INC. 2150 885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address
Thomson Christina (Reporting) CIK: 0001819240 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37490 | Film No.: 201058352